November 15, 2020

Below are some of the new listings of veterinary clinical studies in the AVMA Animal Health Studies Database. Information about participation in the studies is available at the database site.

• AAHSD005179: “A multi-center Phase I/II evaluation of the addition of perioperative and intercalating gefitinib to standard of care treatment for canine osteosarcoma,” Veterinary Cancer & Surgery Specialists, Portland, Oregon.
• AAHSD005180: “Characterization of renal disease in Greyhounds,” The Ohio State University.
• AAHSD005181: “Ketone Cavs: a high MCT diet to treat pain in dogs with syringomyelia,” The Ohio State University.
• AAHSD005189: “Pharmacological tumor microenvironment modification with 3-drug combination in canine metastatic osteosarcoma,” Colorado State University.
• AAHSD005191: “Evaluation of high-frequency irreversible electroporation (H-FIRE) for treatment of canine insulinoma,” Virginia-Maryland College of Veterinary Medicine.
• AAHSD005199: “Study to evaluate the safety and efficacy of rabacfosadine, vincristine, cyclophosphamide, doxorubicin and prednisone in dogs with untreated lymphoma”; Colorado State University; Southwest Veterinary Oncology, Tucson, Arizona; Veterinary Specialty Hospital of the Carolinas, Cary, North Carolina; Oregon State University; and the University of Wisconsin-Madison.
• AAHSD005204: “Randomized, placebo-controlled prospective clinical trial evaluating the use of the Assisi Anti-Anxiety Device for the treatment of canine separation anxiety,” North Carolina State University, recruiting nationwide.